Key result
A rare case of spontaneous coronary artery dissection in a 29-year-old man with antiphospholipid syndrome and leukemia was successfully treated with drug-eluting stent implantation and intensive antithrombotic therapy, with no cardiac events at 10 months.
Case Report (n=1)
SCAD can be a rare manifestation of antiphospholipid syndrome and can be successfully managed with DES implantation and intensive antithrombotic therapy.
We report a rare spontaneous coronary artery dissection (SCAD) case accompanied by antiphospholipid syndrome (APS) and leukemia which was treated successfully with drug-eluted stents (DES) implantation. This young SCAD patient was initially diagnosed of acute myocardial infarction (AMI); however, except for 6 pack-years of smoking, there were no risk factors or family history of coronary artery disease. Subsequently, we screened other clinical status like autoimmune diseases and finally found APS. In general, APS was associated with thromboembolism events, not coronary artery dissection. Our case indicated that SCAD could be a rare manifestation of APS which should draw our attention. In addition, our bail-out therapy acquired the expected effect.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2018) conducted a case report in Spontaneous coronary artery dissection (SCAD) with antiphospholipid syndrome (APS) and leukemia (n=1). Drug-eluting stent (DES) implantation and antithrombotic therapy was evaluated on Symptom relief and absence of cardiac events. A rare case of spontaneous coronary artery dissection in a 29-year-old man with antiphospholipid syndrome and leukemia was successfully treated with drug-eluting stent implantation and intensive antithrombotic therapy, with no cardiac events at 10 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: